Mizuno H, Takahashi Y, Ohno H, Misawa M
Central Research Laboratory, SS Pharmaceutical Co., Ltd., Chiba, Japan.
Nihon Yakurigaku Zasshi. 1990 Jan;95(1):31-40. doi: 10.1254/fpj.95.1_31.
Effects of flutropium bromide, a new bronchodilator with an anticholinergic action, alone or in combination with other antiasthma drugs were investigated in guinea pigs by using an index of inhibition of the acetylcholine (ACh)-induced bronchoconstriction. Single inhalation of flutropium bromide (0.0003%) into the airways of guinea pigs inhibited the ACh (i.v.)-induced bronchoconstriction without changing the fall in blood pressure induced by ACh. When salbutamol (3 micrograms/kg, i.v.), aminophylline (5 mg/kg, i.v.) or disodium cromoglycate (10 mg/kg, i.v.) was administered in combination with flutropium bromide (0.0003%), bronchodilation was enhanced as compared with single administration of the respective antiasthma drugs. From the above results, it is indicated that inhalation of flutropium bromide provides a more efficient bronchodilation in combination with other antiasthma drugs that possess different mechanisms of antiasthma effects.
使用乙酰胆碱(ACh)诱导支气管收缩的抑制指标,在豚鼠中研究了新型具有抗胆碱能作用的支气管扩张剂溴化氟托品单独使用或与其他抗哮喘药物联合使用的效果。向豚鼠气道单次吸入溴化氟托品(0.0003%)可抑制ACh(静脉注射)诱导的支气管收缩,而不改变ACh诱导的血压下降。当沙丁胺醇(3微克/千克,静脉注射)、氨茶碱(5毫克/千克,静脉注射)或色甘酸钠(10毫克/千克,静脉注射)与溴化氟托品(0.0003%)联合给药时,与单独使用各自的抗哮喘药物相比,支气管扩张作用增强。从上述结果表明,与具有不同抗哮喘作用机制的其他抗哮喘药物联合使用时,吸入溴化氟托品可提供更有效的支气管扩张作用。